AXSM News and Press, Axsome Therapeutics Inc. From 06/15/23

2023-06-15 14:00:00 ET The best biotech growth stocks typically have one clear-cut value driver. This fact is a testament to the extreme difficulty involved in bringing a major new drug to market and subsequently capturing market share. As a result, a large chunk of small- to mid-cap biotec...

2023-06-14 16:21:43 ET Summary Axsome Therapeutics, Inc. NDA resubmission of AXS-07 for treatment of patients with migraine expected 2nd half 2023 after FDA meeting determined that CMC issues are the only things that need to be addressed. It is expected that the global migraine dr...

2023-06-10 06:14:00 ET Sell in May and go away? The old adage hasn't proven to be great advice in 2023. The stock market has risen so far in June and could go even higher. Three Motley Fool contributors think some stocks are no-brainers to buy this month. Here's why they especially like...

NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced presentations on Sunosi ® (solriamfetol) at SLEEP 2023...

Data on Auvelity demonstrating improved functioning in major depressive disorder Data on Sunosi demonstrating improved cognitive function in patients with excessive daytime sleepiness associated with obstructive sleep apnea NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Axsome Therape...

2023-05-28 10:15:00 ET The next 12 months could be dicey for the economy and the stock market, especially as the U.S. Federal Reserve recently predicted a recession could come by year-end. But even in this environment, some equities should perform just fine -- or even better. Let's look...

2023-05-22 07:45:00 ET Equities experienced a bear market in 2022, and although things have improved significantly over the past few months, it's impossible to say whether we are out of the woods. However, some corporations have managed solid performances throughout this period. This group ...

2023-05-17 05:30:00 ET Axsome Therapeutics (NASDAQ: AXSM) wowed investors late last year with strong data from a phase 3 study of AXS-05, its candidate treatment for Alzheimer's disease agitation. AXS-05 met its primary and secondary goals in the study, and importantly, looked to be...

2023-05-15 13:54:00 ET Summary Axsome Therapeutics, Inc. has come a long way since its early year as a clinical-stage innovator. The company is enjoying early launch success for its two stellar medicines (Auvelity and Sunosi). Stacked by many catalysts this year and beyond, yo...

2023-05-13 08:00:00 ET The stock market's short-term volatility can sometimes cloud investors' judgment and cause panic selling. But history has demonstrated time and again that a buy-and-hold strategy is one of the best ways for the average person to generate wealth. So it pays to target s...